ArticleThe World Allergy Organization journal2022

Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience.

Mohamed Abuzakouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.